haloperidol and ondansetron

haloperidol has been researched along with ondansetron in 52 studies

Research

Studies (52)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (3.85)	18.7374
1990's	8 (15.38)	18.2507
2000's	18 (34.62)	29.6817
2010's	20 (38.46)	24.3611
2020's	4 (7.69)	2.80

Authors

Authors	Studies
Calderó, JM; del Río, J; García, E; Lasheras, B; Monge, A; Palop, JA; Peña, MC; Roca, J; Romero, G	1
Topliss, JG; Yoshida, F	1
Keserü, GM	1
Nagashima, R; Nishikawa, T; Tobita, M	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Jia, L; Sun, H	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Sen, S; Sinha, N	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Artursson, P; Mateus, A; Matsson, P	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Peltier, R; Schenk, S	1
Koulu, M; Lappalainen, J; Sjöholm, B; Virtanen, R	1
Costall, B; Gunning, SJ; Naylor, RJ; Tyers, MB	1
Cole, RM; Harvey, L; Murdoch, V; Robinson, F; Trethowan, K	1
Allison, K; Arnold, B; Greenshaw, AJ; Ivanová, S; Paetsch, PR; Paslawski, T	1
Feldon, J; Gray, JA; Joseph, MH; Warburton, EC; Weiner, I	1
Borg, PJ; Taylor, DA	1
Mol, CA; Schinkel, AH; van Deemter, L; Wagenaar, E	1
Greenshaw, AJ; Ivanová, S	1
Kulkarni, SK; Naidu, PS	1
Bauzon, D; Bymaster, FP; Cohen, ML; DeLapp, NW; Falcone, JF; Kennedy, JS; Schenck, K	1
De Deurwaerdère, P; Moison, D; Porras, G; Spampinato, U	1
Aouad, MT; Azar, MS; Baraka, AS; Hakki, MA; Nasr, VG; Siddik-Sayyid, SM; Taha, SK; Zoorob, DG	1
Kang, WH; Li, Q; Ma, AQ; Wang, XY; Yao, SM; Zhang, ZJ	1
Chu, CC; Lai, HY; Lee, Y; Wang, JJ; Wang, PK; Yang, YL	1
Gan, TJ; Habib, AS	1
Bittner, EA; Grecu, L; Haspel, KL; Rosow, CE; Smith, SE	1
Bittner, EA; Grecu, L; Kher, J; Rosow, CE; Smith, SE	1
Dagtekin, O; Hermann, MM; Kampe, S; Pietruck, C; Wiese, P; Wolter, K	1
Chu, CC; Chu, KS; Feng, PH; Ho, ST; Lu, IC; Shieh, JP; Tzeng, JI; Wang, JJ	1
Huang, CC; Huang, SJ; Lai, HY; Lee, Y; Lin, PC; Tsay, PJ; Wang, PK	1
Daskalopoulos, ME; Gogaki, E; Papaliagkas, V; Parisis, C; Sataitidis, I; Tagarakis, GI; Tsagalas, I; Tsilimingas, NB; Tsolaki, F; Tsolaki, M; Voucharas, C	1
Ashton, JC; Jain, S; Mandhane, S; Nayak, P; Rajamannar, T; Soni, D	1
Armahizer, MJ; Kane-Gill, SL; Seybert, AL; Smithburger, PL	1
Benevides, ML; de Aguilar-Nascimento, JE; Oliveira, SS	1
Bennett, MI; Blenkinsopp, A; McLean, SL	1
Iwata, N; Kishi, T; Matsuda, Y; Mukai, T	1
Callejas, R; Carrascosa, F; Duque, P; López-Olaondo, L; Pueyo, J; Veiga-Gil, L	1
Brettner, F; Chappell, D; Janitza, S; Jovanovic, A; Küchenhoff, H; Mansmann, U; Pollwein, B; Prüll, K; von Dossow, V; Weninger, E; Zwissler, B	1
Aouad, MT; Barakat, HB; Korjian, S; Siddik-Sayyid, SM; Yazbeck-Karam, VG	1
Abbasi-Maleki, S; Mesbahzadeh, B; Moradi-Kor, N	1
Acharya, B; Dulal, S; Neupane, P; Paudel, BD; Poudyal, BS; Shah, A; Shilpakar, R; Wood, LA	1
Crawford, FM; Day, AG; Forrester, S; Hall, AK; Ruberto, AJ; Sivilotti, MLA	1
Crawford, FM; Hall, AK; Ruberto, AJ; Sivilotti, MLA	1
Genest, M; Moussa, G; Villeneuve, E; Wang, JJ	1
Akiba, Y; Kaunitz, JD; Satoh, H; Urushidani, T	1

Reviews

3 review(s) available for haloperidol and ondansetron

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Using haloperidol as an antiemetic in palliative care: informing practice through evidence from cancer treatment and postoperative contexts. Journal of pain & palliative care pharmacotherapy, 2013, Volume: 27, Issue:2 Topics: Antiemetics; Antineoplastic Agents; Haloperidol; Humans; Nausea; Ondansetron; Palliative Care; Postoperative Nausea and Vomiting; Treatment Outcome; Vomiting	2013
Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review. Neuromolecular medicine, 2014, Volume: 16, Issue:1 Topics: Antipsychotic Agents; Constipation; Double-Blind Method; Drug Therapy, Combination; Granisetron; Haloperidol; Humans; Indoles; Nausea; Ondansetron; Randomized Controlled Trials as Topic; Receptors, Serotonin, 5-HT3; Risperidone; Schizophrenia; Serotonin 5-HT3 Receptor Antagonists; Severity of Illness Index; Symptom Assessment; Treatment Outcome; Tropisetron; Vomiting	2014

Trials

13 trial(s) available for haloperidol and ondansetron

Article	Year
Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery. European journal of anaesthesiology, 2007, Volume: 24, Issue:2 Topics: Adult; Analysis of Variance; Anesthesia, General; Antiemetics; Double-Blind Method; Female; Gynecologic Surgical Procedures; Haloperidol; Humans; Injections, Intravenous; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome	2007
Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study. Schizophrenia research, 2006, Volume: 88, Issue:1-3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chronic Disease; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Resistance; Female; Haloperidol; Humans; Male; Middle Aged; Ondansetron; Schizophrenia	2006
Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting. Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2007, Volume: 54, Issue:5 Topics: Adult; Anesthesia Recovery Period; Anesthesia, General; Anesthesia, Inhalation; Antiemetics; Double-Blind Method; Female; Haloperidol; Humans; Incidence; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Risk Factors; Time Factors	2007
Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting. Anesthesia and analgesia, 2008, Volume: 106, Issue:5 Topics: Adult; Aged; Antiemetics; Elective Surgical Procedures; Female; Haloperidol; Heart Conduction System; Humans; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome	2008
Haloperidol plus ondansetron versus ondansetron alone for prophylaxis of postoperative nausea and vomiting. Anesthesia and analgesia, 2008, Volume: 106, Issue:5 Topics: Adult; Aged; Antiemetics; Double-Blind Method; Drug Therapy, Combination; Elective Surgical Procedures; Female; Haloperidol; Humans; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Time Factors; Treatment Outcome	2008
Haloperidol versus haloperidol plus ondansetron for the prophylaxis of postoperative nausea and vomiting after ophthalmologic surgery. Pharmacology, 2009, Volume: 83, Issue:4 Topics: Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Middle Aged; Ondansetron; Ophthalmologic Surgical Procedures; Pain Measurement; Pain, Postoperative; Postoperative Nausea and Vomiting; Risk Factors; Time Factors	2009
Haloperidol plus ondansetron prevents postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy. Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of Anesthesiologists, 2009, Volume: 47, Issue:1 Topics: Adult; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Ondansetron; Postoperative Nausea and Vomiting	2009
Comparison of dexamethasone with ondansetron or haloperidol for prevention of patient-controlled analgesia-related postoperative nausea and vomiting: a randomized clinical trial. World journal of surgery, 2012, Volume: 36, Issue:4 Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Dexamethasone; Drug Therapy, Combination; Female; Haloperidol; Humans; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Treatment Outcome	2012
Ondasetron versus haloperidol for the treatment of postcardiotomy delirium: a prospective, randomized, double-blinded study. Journal of cardiothoracic surgery, 2012, Mar-21, Volume: 7 Topics: Aged; Aged, 80 and over; Analysis of Variance; Cardiac Surgical Procedures; Delirium; Double-Blind Method; Female; Haloperidol; Humans; Male; Neuropsychological Tests; Ondansetron; Postoperative Complications; Prospective Studies	2012
The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial. Obesity surgery, 2013, Volume: 23, Issue:9 Topics: Adult; Analgesics, Opioid; Antiemetics; Brazil; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Fluid Therapy; Gastroplasty; Haloperidol; Humans; Length of Stay; Male; Morphine; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Quality of Life; Treatment Outcome	2013
Haloperidol Versus Ondansetron for Treatment of Established Nausea and Vomiting Following General Anesthesia: A Randomized Clinical Trial. Anesthesia and analgesia, 2017, Volume: 124, Issue:2 Topics: Administration, Intravenous; Adult; Aged; Anesthesia, General; Antiemetics; Double-Blind Method; Electrocardiography; Female; Haloperidol; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Treatment Outcome	2017
Randomized Phase II Trial to Compare the Efficacy of Haloperidol and Olanzapine in the Control of Chemotherapy-Induced Nausea and Vomiting in Nepal. Journal of global oncology, 2019, Volume: 5 Topics: Administration, Intravenous; Administration, Oral; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Nausea; Neoplasms; Olanzapine; Ondansetron; Random Allocation; Treatment Outcome; Vomiting; Young Adult	2019
Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial. Annals of emergency medicine, 2021, Volume: 77, Issue:6 Topics: Administration, Intravenous; Adult; Antiemetics; Female; Haloperidol; Humans; Male; Marijuana Abuse; Ondansetron; Pain Measurement; Syndrome; Vomiting	2021

Other Studies

36 other study(ies) available for haloperidol and ondansetron

Article	Year
Synthesis of 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties. Journal of medicinal chemistry, 1994, Apr-29, Volume: 37, Issue:9 Topics: Animals; Benzothiazoles; Binding, Competitive; Cerebral Cortex; Female; Gastric Emptying; Granisetron; Guinea Pigs; Ileum; Male; Molecular Structure; Mucous Membrane; Ondansetron; Piperazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles	1994
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship	2003
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. Bioorganic & medicinal chemistry letters, 2005, Jun-02, Volume: 15, Issue:11 Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Support vector machines classification of hERG liabilities based on atom types. Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11 Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. European journal of medicinal chemistry, 2011, Volume: 46, Issue:2 Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship	2011
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
A high-throughput cell-based method to predict the unbound drug fraction in the brain. Journal of medicinal chemistry, 2014, Apr-10, Volume: 57, Issue:7 Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2014
GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats. Pharmacology, biochemistry, and behavior, 1991, Volume: 39, Issue:1 Topics: Animals; Cocaine; Dose-Response Relationship, Drug; Haloperidol; Imidazoles; Injections, Intravenous; Male; Ondansetron; Rats; Rats, Inbred Strains; Self Administration; Serotonin Antagonists	1991
Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons. European journal of pharmacology, 1989, Oct-10, Volume: 169, Issue:2-3 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Imidazoles; Limbic System; Male; Neurons; Nucleus Accumbens; Ondansetron; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Substantia Nigra	1989
The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig. British journal of pharmacology, 1987, Volume: 91, Issue:2 Topics: Animals; Gastric Emptying; Guinea Pigs; Haloperidol; Imidazoles; Metoclopramide; Ondansetron; Serotonin Antagonists	1987
Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer. Journal of pain and symptom management, 1994, Volume: 9, Issue:1 Topics: Analgesics; Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Female; Haloperidol; Humans; Middle Aged; Morphine; Nausea; Ondansetron; Pain; Palliative Care; Vomiting	1994
5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats. Psychopharmacology, 1995, Volume: 119, Issue:2 Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Granisetron; Haloperidol; Indoles; Male; Motor Activity; Nicotine; Ondansetron; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Time Factors; Tropanes; Tropisetron	1995
Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron. Psychopharmacology, 1994, Volume: 114, Issue:4 Topics: Acoustic Stimulation; Amphetamine; Animals; Antipsychotic Agents; Conditioning, Operant; Dopamine; Electroshock; Emotions; Haloperidol; Male; Ondansetron; Rats; Rats, Sprague-Dawley; Serotonin Antagonists	1994
Voluntary oral morphine self-administration in rats: effect of haloperidol or ondansetron. Pharmacology, biochemistry, and behavior, 1994, Volume: 47, Issue:3 Topics: Animals; Behavior, Animal; Defecation; Haloperidol; Injections, Intramuscular; Male; Morphine; Morphine Dependence; Naloxone; Ondansetron; Quinine; Rats; Rats, Wistar; Self Administration; Substance Withdrawal Syndrome	1994
P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. The Journal of clinical investigation, 1996, Jun-01, Volume: 97, Issue:11 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Cell Line; Clozapine; Diffusion; Domperidone; Epithelium; Flunitrazepam; Haloperidol; Humans; Kidney; Kinetics; Loperamide; Male; Mice; Mice, Inbred Strains; Ondansetron; Phenytoin; Recombinant Proteins; Structure-Activity Relationship; Swine; Tissue Distribution; Transfection	1996
Nicotine-induced decreases in VTA electrical self-stimulation thresholds: blockade by haloperidol and mecamylamine but not scopolamine or ondansetron. Psychopharmacology, 1997, Volume: 134, Issue:2 Topics: Animals; Conditioning, Operant; Dopamine Antagonists; Haloperidol; Male; Mecamylamine; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Ondansetron; Rats; Rats, Sprague-Dawley; Scopolamine; Self Stimulation; Serotonin Antagonists; Ventral Tegmental Area	1997
Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists. European journal of pharmacology, 2001, May-25, Volume: 420, Issue:2-3 Topics: Animals; Antipsychotic Agents; Behavior, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Haloperidol; Indoles; Male; Ondansetron; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Tropisetron	2001
Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine. European journal of pharmacology, 2001, Nov-02, Volume: 430, Issue:2-3 Topics: Animals; Benzodiazepines; Binding, Competitive; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Haloperidol; HeLa Cells; Humans; Ileum; In Vitro Techniques; Indoles; Lysergic Acid; Muscle Contraction; Olanzapine; Ondansetron; Pirenzepine; Quetiapine Fumarate; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfur Radioisotopes; Tritium; Tropisetron	2001
Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum. The European journal of neuroscience, 2003, Volume: 17, Issue:4 Topics: Amphetamine; Analgesics, Opioid; Animals; Brain Chemistry; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Citalopram; Cocaine; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Electrochemistry; Haloperidol; Male; Microdialysis; Morphine; Ondansetron; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT3 Receptor Antagonists; Tropanes	2003
Haloperidol for postoperative nausea and vomiting: are we reinventing the wheel? Anesthesia and analgesia, 2008, Volume: 106, Issue:5 Topics: Antiemetics; Cost-Benefit Analysis; Droperidol; Drug Approval; Drug Costs; Drug Labeling; Drug Therapy, Combination; Drugs, Generic; Europe; Haloperidol; Heart Conduction System; Humans; Ondansetron; Postoperative Nausea and Vomiting; United States; United States Food and Drug Administration	2008
Induction of glucose intolerance by acute administration of rimonabant. Pharmacology, 2012, Volume: 89, Issue:5-6 Topics: Administration, Oral; Animals; Benzoxazines; Blood Glucose; Dopamine Antagonists; Eating; Fenclonine; Glucose; Glucose Intolerance; Haloperidol; Hepatocytes; Infusions, Intraventricular; Insulin; Male; Mice; Morpholines; Naphthalenes; Ondansetron; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Dopamine; Receptors, Serotonin; Rimonabant; Serotonin Antagonists	2012
Drug-drug interactions contributing to QT prolongation in cardiac intensive care units. Journal of critical care, 2013, Volume: 28, Issue:3 Topics: Amiodarone; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Anti-Infective Agents; Antipsychotic Agents; Biomarkers, Pharmacological; Drug Interactions; Electrocardiography; Female; Haloperidol; Humans; Intensive Care Units; Long QT Syndrome; Male; Metronidazole; Middle Aged; Ondansetron; Retrospective Studies; Risk Factors	2013
Low doses of haloperidol combined with ondansetron are not effective for prophylaxis of postoperative nausea and vomiting in susceptible patients. Cirugia espanola, 2015, Volume: 93, Issue:2 Topics: Adolescent; Adult; Aged; Antiemetics; Cohort Studies; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Retrospective Studies; Treatment Failure; Young Adult	2015
Gender-Specific Differences in Low-Dose Haloperidol Response for Prevention of Postoperative Nausea and Vomiting: A Register-Based Cohort Study. PloS one, 2016, Volume: 11, Issue:1 Topics: Aged; Analgesics, Opioid; Anesthesia, General; Antiemetics; Cohort Studies; Female; Haloperidol; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Ondansetron; Pain Management; Pain, Postoperative; Postoperative Nausea and Vomiting; Postoperative Period; Registries; Regression Analysis; Sex Factors; Universities	2016
Zinc enhances the expression of morphine-induced conditioned place preference through dopaminergic and serotonergic systems. Biomolecular concepts, 2019, Apr-03, Volume: 10, Issue:1 Topics: Animals; Benzazepines; Conditioning, Psychological; Dopamine Antagonists; Haloperidol; Ketanserin; Male; Morphine; Ondansetron; Piperazines; Rats; Rats, Wistar; Reward; Serotonin Antagonists; Sulpiride; Zinc	2019
Annals of emergency medicine, 2021, Volume: 77, Issue:5 Topics: Cannabis; Haloperidol; Humans; Ondansetron; Syndrome; Vomiting	2021
Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial. Annals of emergency medicine, 2021, Volume: 77, Issue:5 Topics: Antiemetics; Cannabis; Female; Haloperidol; Humans; Hyperemesis Gravidarum; Ondansetron; Pregnancy; Vomiting	2021
Gastroparesis Worsens Indomethacin-Induced Gastric Antral Ulcers by Bile Reflux via Activation of 5-HT Digestive diseases and sciences, 2023, Volume: 68, Issue:10 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Apomorphine; Atropine; Bile Reflux; Cholestyramine Resin; Dopamine; Duodenogastric Reflux; Gastroparesis; Haloperidol; Indomethacin; Mice; Ondansetron; Serotonin; Stomach Ulcer; Ulcer	2023